My watch list
my.bionity.com  
Login  
NEWS
Current news

Making it easier to differentiate mirror-image molecules

Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light

06-Jul-2022 Using a new method, scientists are better able to distinguish between mirror-image substances. This is important amongst others in drug development, because the two variants can cause completely different effects in the human body. Researchers from Paul Scherrer Institute PSI, EPF Lausanne ... more

How to find marker genes in cell clusters

New method facilitates identification of cell-type specific genes in single-cell data

06-Jul-2022 The thousands of cells in a biological sample are all different and can be analyzed individually, cell by cell. Based on their gene activity, they can be sorted into clusters. But which genes are particularly characteristic of a given cluster, i.e. what are its “marker genes”? A new statist ... more

The benefits of exercise in a pill?

Science is closer to that goal

06-Jul-2022 Researchers at Baylor College of Medicine, Stanford School of Medicine and collaborating institutions report in the journal Nature that they have identified a molecule in the blood that is produced during exercise and can effectively reduce food intake and obesity in mice. The findings impr ... more

Evotec completes acquisition of Rigenerand

05-Jul-2022 Evotec SE announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed. Based out of Medolla, Italy, the cell technology company with leading edge in the field of cGMP manufacturing of cell therapies will operate as Evotec (Modena) Srl going for ... more

On the way to cell-type materials

Physicists decode the dynamic interaction between molecular machines in metal-organic frameworks

05-Jul-2022 Molecular machines control a sizeable number of fundamental processes in nature. Embedded in a cellular environment, these processes play a central role in the intracellular and intercellular transportation of molecules, as well as in muscle contraction in humans and animals. In order for t ... more

Emerging Omicron subvariants are inhibited less efficiently by antibodies

Infections with the "old" omicron subvariants BA.1 and BA.2 provide little protection against the SARS-CoV-2 subvariant BA.5 causing a “summer wave” of cases in Germany

05-Jul-2022 The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current uptick of cases in Germany. However, it is at present largely unc ... more

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Investment will fund genomics startups for Illumina Accelerator Cambridge graduates

05-Jul-2022 Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in ... more

Detection of cancer biomarkers from blood samples using nanopore-based DNA computing technology

05-Jul-2022 Cholangiocarcinoma, also known as bile duct cancer, is a cancer type with a characteristically high mortality. At the time of diagnosis, most bile duct cancers are typically already incurable. This is why methods for the early diagnosis of bile duct cancer are urgently needed. Liquid biopsy ... more

Start-up NextImmune supported by Venture Kick

Development of selective immunosuppressive drugs

05-Jul-2022 NextImmune, a spin-off from the Biozentrum of the University of Basel, has received financial support of 150,000 Swiss francs from the Venture Kick funding initiative. The start-up develops a new generation of immunosuppressive drugs for autoimmune diseases and organ transplantation. The co ... more

How bacteria adhere to cells: Basis for the development of a new class of antibiotics

04-Jul-2022 The adhesion of bacteria to host cells is always the first and one of the decisivesteps in the development of infectious diseases. The purpose of this adhesion by infectious pathogens is first to colonize the host organism (i.e., the human body), and then to trigger an infection, which in t ... more

All news

How to find marker genes in cell clusters

New method facilitates identification of cell-type specific genes in single-cell data

06-Jul-2022 The thousands of cells in a biological sample are all different and can be analyzed individually, cell by cell. Based on their gene activity, they can be sorted into clusters. But which genes are particularly characteristic of a given cluster, i.e. what are its “marker genes”? A new statist ... more

Shining some light on the obscure proteome

Chemoproteomics draw the target landscape of HDAC drugs

01-Jul-2022 Mass-spectrometry based proteomics is the big-data science of proteins that allows the monitoring of the abundance of thousands of proteins in a sample at once. Therefore, it is a particularly well-suited readout for discovering which proteins are targeted by any small molecule. An internat ... more

Mass spectrometry-based draft of the mouse proteome

A milestone for biomedical research

30-Jun-2022 Proteins control and organize almost every aspect of life. The totality of all proteins in a living organism, a tissue or a cell is called the proteome. Using mass spectrometry, researchers at the Technical University of Munich (TUM) characterize the proteome, or protein complement of the g ... more

analytica 2022 wowed the laboratory industry

analytica extended: digital extension through July 8

27-Jun-2022 An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for ... more

Tapping the ocean as a source of natural products

New species and new molecules discovered

24-Jun-2022 Using DNA data, ETH researchers have examined seawater to find not only new species of bacteria, but also previously unknown natural products that may one day prove beneficial. The oceans are teeming with countless forms of life, from the world’s largest creature – the blue whale – to minis ... more

Scientists create luminescent gels with multitude of applications from counterfeiting to bio-sensing

15-Jun-2022 Scientists from Trinity College Dublin have taken inspiration from nature to create luminescent, self-healing gels with a suite of potential applications ranging from bank note counterfeiting to next-gen bio-sensing and imaging. Crucially, the scientists have been able to introduce guanosin ... more

Chromatin originated in ancient microbes one to two billion years ago

Genomic and proteomic analysis reveals that the regulatory role of chromatin is a eukaryotic innovation

13-Jun-2022 In almost every human cell, two metres-long DNA has to fit within a nucleus that is just 8 millionths of a metre wide. Like wool around a spool, the extreme space challenge requires DNA to wrap around structural proteins called histones. This coiled genetic architecture, known as chromatin, ... more

Inspiration for the laboratory of tomorrow

analytica 2022 supporting program

08-Jun-2022 Live in Munich again at last: When analytica, the world’s leading trade fair for laboratory technology, analysis and biotechnology, opens its doors from June 21 to 24, around 900 exhibitors will present their innovations. The industry is particularly looking forward to in-person dialog. The ... more

Magnetic resonance imaging shows brain inflammation in vivo for the first time

Researchers have obtained for the first time images of the activation of microglia and astrocytes

31-May-2022 Research of the laboratories led by Dr. Silvia de Santis and Dr. Santiago Canals, both from the Institute of Neurosciences UMH-CSIC (Alicante, Spain), has made it possible to visualize for the first time and in great detail brain inflammation using diffusion-weighted Magnetic Resonance Imag ... more

Magnetic resonance makes the invisible visible

Hyperpolarised water boosts signal intensities of proteins, DNA, and membranes

20-May-2022 A small group of researchers including Dennis Kurzbach from the Faculty of Chemistry of the University of Vienna just published in "Nature Protocols" an advanced NMR (Nuclear Magnetic Resonance) method to monitor fast and complicated biomolecular events such as protein folding. For example, ... more

All news on bioanalytics

Evotec completes acquisition of Rigenerand

05-Jul-2022 Evotec SE announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed. Based out of Medolla, Italy, the cell technology company with leading edge in the field of cGMP manufacturing of cell therapies will operate as Evotec (Modena) Srl going for ... more

Start-up NextImmune supported by Venture Kick

Development of selective immunosuppressive drugs

05-Jul-2022 NextImmune, a spin-off from the Biozentrum of the University of Basel, has received financial support of 150,000 Swiss francs from the Venture Kick funding initiative. The start-up develops a new generation of immunosuppressive drugs for autoimmune diseases and organ transplantation. The co ... more

New PET Hydrolase

Enzyme in salivary microbes decomposes PET-based plastics

04-Jul-2022 Human saliva may contain an enzyme which can decompose the plastic polyethylene terephthalate (PET). Researchers found the promising enzyme, a hydrolase, in a database containing human metagenome samples. As they report in the journal Angewandte Chemie, this newly discovered hydrolase perfo ... more

Bacteria for blastoff: Using microbes to make supercharged new rocket fuel

Scientists have developed a new class of energy-dense biofuels based on one of nature’s most unique molecules

04-Jul-2022 Converting petroleum into fuels involves crude chemistry first invented by humans in the 1800s. Meanwhile, bacteria have been producing carbon-based energy molecules for billions of years. Which do you think is better at the job? Well aware of the advantages biology has to offer, a group of ... more

Who trusts gene-edited foods?

New study gauges public acceptance

01-Jul-2022 Through CRISPR and other gene-editing technologies, researchers and developers are poised to bring dozens – if not hundreds – of new products to grocery stores: mushrooms with longer shelf lives, drought-resistant corn and bananas impervious to a fungus threatening the global supply. A few, ... more

New biobatteries use bacterial interactions to generate power for weeks

'Plug-and-play' features allow batteries to be wired together for increased power

30-Jun-2022 Researchers at Binghamton University, State University of New York have developed a “plug-and-play” biobattery that lasts for weeks at a time and can be stacked to improve output voltage and current. As our tech needs grow and the Internet of Things increasingly connects our devices and sen ... more

WACKER to Invest Double-Digit Million-Euro Sum in Biotechnology Center

The product portfolio is to expand through innovation, partnerships and acquisitions

29-Jun-2022 The WACKER Group is concentrating its biotechnology research activities in Munich. The company is investing a double-digit million-euro sum in the construction of a Biotechnology Center, which is scheduled to be operational in 2024. This investment will strengthen WACKER’s biotechnology bus ... more

New PET-like plastic made directly from waste biomass

“We essentially just ‘cook’ wood or other non-edible plant material, such as agricultural wastes, in inexpensive chemicals to produce the plastic precursor in one step”

28-Jun-2022 It is becoming increasingly obvious that moving away from fossil fuels and avoiding the accumulation of plastics in the environment are key to addressing the challenge of climate change. In that vein, there are considerable efforts to develop degradable or recyclable polymers made from non- ... more

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

27-Jun-2022 Merck announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new €59 million, 70,000 square foot facility, officially opened, b ... more

A fine-tuned gene editor

Spacing out the cuts

27-Jun-2022 The molecular tool CRISPR-Cas9 can be used to treat inherited blood disorders, but this may cause unintended genetic alterations. A team led by MDC researchers Klaus Rajewsky and Van Trung Chu has now presented an approach in “Science Advances” that minimizes such adverse consequences. Hope ... more

All news on biotechnology

Detection of cancer biomarkers from blood samples using nanopore-based DNA computing technology

05-Jul-2022 Cholangiocarcinoma, also known as bile duct cancer, is a cancer type with a characteristically high mortality. At the time of diagnosis, most bile duct cancers are typically already incurable. This is why methods for the early diagnosis of bile duct cancer are urgently needed. Liquid biopsy ... more

New fluorophores could help fight cancer

Scientists synthesized inexpensive substances for diagnosis and therapy of tumors

30-Jun-2022 Scientists from the Ural Federal University and the Ural Branch of the Russian Academy of Sciences have created new fluorescent chemical compounds (fluorophores) for photodynamic therapy of cancerous tumors, the latest method of treating cancer. The compound is suitable simultaneously for t ... more

Tears instead of Blood

Sensor with separation capability: diagnosing jaundice using tear fluids

28-Jun-2022 Human tear fluids contain many proteins, metabolites, and other molecules whose concentrations change significantly with certain diseases. A research team has now developed a handy test kit for tears that can identify patients with jaundice. Their success is based on a hybrid sensor that si ... more

Wearable chemical sensor is as good as gold

A novel Raman chemical sensor made from noodlelike threads of gold

27-Jun-2022 Researchers created a special ultrathin sensor, spun from gold, that can be attached directly to the skin without irritation or discomfort. The sensor can measure different biomarkers or substances to perform on-body chemical analysis. It works using a technique called Raman spectroscopy, w ... more

analytica 2022 wowed the laboratory industry

analytica extended: digital extension through July 8

27-Jun-2022 An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for ... more

Breakthrough: Prospect of blood test for Parkinson’s disease for the first time

A new method reliably detects protein changes in blood that are typical of Parkinson's disease: "The results are really sensational"

22-Jun-2022 Until now, the diagnosis of Parkinson's disease has been based primarily on typical movement disorders such as muscle stiffness, slower movements and shaking. However, the disease starts up to twenty years before it becomes noticeable as a result of these symptoms. To date, there have been ... more

AI identifies cancer cells

“Ikarus lets us identify genes that are potential drivers of cancer”

14-Jun-2022 How do cancer cells differ from healthy cells? A new machine learning algorithm called “ikarus” knows the answer, reports a team led by MDC bioinformatician Altuna Akalin in the journal Genome Biology. The AI program has found a gene signature characteristic of tumors. When it comes to iden ... more

Meteorite impact in the brain

Treatment of acute stroke in personalized medicine

10-Jun-2022 A blood clot in the brain that blocks the supply of oxygen can cause an acute stroke. In this case, every minute counts. A team from Empa, the University Hospital in Geneva and the Hirslanden Clinic is currently developing a diagnostic procedure that can be used to start a tailored therapy ... more

R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist

09-Jun-2022 R-Biopharm AG announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment. The company is there ... more

Inspiration for the laboratory of tomorrow

analytica 2022 supporting program

08-Jun-2022 Live in Munich again at last: When analytica, the world’s leading trade fair for laboratory technology, analysis and biotechnology, opens its doors from June 21 to 24, around 900 exhibitors will present their innovations. The industry is particularly looking forward to in-person dialog. The ... more

All news on diagnostics

analytica 2022 wowed the laboratory industry

analytica extended: digital extension through July 8

27-Jun-2022 An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for ... more

R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist

09-Jun-2022 R-Biopharm AG announced the acquisition of AusDiagnostics. R-Biopharm is expanding its product portfolio with the addition of the Australian specialist and manufacturer of molecular biology multiplex diagnostics, extraction reagents, and laboratory automation equipment. The company is there ... more

Eppendorf increases 2021 revenue to €1.1 billion

Positive trends in all market regions and product groups

11-May-2022 During fiscal year 2021, the globally positioned Eppendorf Group saw its consolidated revenue climb to €1.1 billion (prior year: €967.2 million), amounting to an increase of 13.8% (prior year: 20.3%). Operating profit also rose significantly in 2021, reaching €272 million (prior year: €217. ... more

Eppendorf builds new site in Wismar for high-tech polymers used in laboratories

Production to start by the end of the year

25-Apr-2022 The globally active Eppendorf Group is building a new plant for high-quality laboratory consumables made of functional high-tech polymers. To this end, the Hamburg-based life science company is acquiring a former production site at the location of MV Werften Fertigmodule Property GmbH in Wi ... more

Sartorius records dynamic start to the new fiscal year

Global political and economic uncertainties substantially increased

22-Apr-2022 Sartorius recorded a dynamic start to fiscal 2022, with sales revenue and earnings posting strong double-digit growth rates in the first quarter compared with the prior-year period. Based on its performance in the first three months, Sartorius confirms its outlook for fiscal 2022. “Sartoriu ... more

analytica 2022: Fighting COVID-19 with combined expertise

New tools in virus research and detection

22-Mar-2022 Whether PCR apps or high-tech analysis equipment for vaccine development: during the pandemic, the chemical analysis and biotech sector has demonstrated its strength. From June 21 to 24, 2022, the industry will come together in Munich at analytica, the leading trade fair for analysis, labor ... more

Hahnemühle appoints new international leadership team

Three appointments complete important steps in Hahnemühle’s Go-to-Market strategy

01-Mar-2022 Hahnemühle is delighted to announce the appointments of Nancy Janes to the position of Hahnemühle UK & Ireland Managing Director and General Manager, Sven Heeren to the position of General Manager DACH & The Netherlands and Simon Waller to the position General Manager Hahnemühle USA. All ap ... more

Semarion raises £2.14 million GBP seed funding

Semarion’s cell assaying platform turns adherent cells into liquid reagents to enable novel drug screening methodologies

24-Feb-2022 Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, announced that it has closed a £2.14 million GBP seed funding round. The investment round was led by Parkwalk Advisor ... more

analytica 2022—Your path to Laboratory 4.0

Special show brings the digital transformation in the lab to life

24-Feb-2022 Smart solutions for the digital transformation of the laboratory are the main topic of analytica, the leading trade fair for analysis, laboratory technology and biotechnology, which will open its doors from June 21 to 24, 2022 on the Messe München exhibition grounds. Electronic lab journals ... more

BMH invests in developer of sustainable cell cultivation systems

Green Elephant Biotech closes pre-seed funding round

15-Feb-2022 Beteiligungs-Managementgesellschaft Hessen mbH ("BMH"), the medium-sized investment and venture capital company of the State of Hesse, is investing in Green Elephant Biotech GmbH. In addition to the lead investor BMH, a consortium of industry-experienced business angels also participated in ... more

All news on laboratory equipment / laboratory supplies

Evotec completes acquisition of Rigenerand

05-Jul-2022 Evotec SE announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed. Based out of Medolla, Italy, the cell technology company with leading edge in the field of cGMP manufacturing of cell therapies will operate as Evotec (Modena) Srl going for ... more

Start-up NextImmune supported by Venture Kick

Development of selective immunosuppressive drugs

05-Jul-2022 NextImmune, a spin-off from the Biozentrum of the University of Basel, has received financial support of 150,000 Swiss francs from the Venture Kick funding initiative. The start-up develops a new generation of immunosuppressive drugs for autoimmune diseases and organ transplantation. The co ... more

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

27-Jun-2022 Merck announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new €59 million, 70,000 square foot facility, officially opened, b ... more

Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design

Collaboration leverages Iktos’ capabilities in machine learning and AI and Zealand expertise in peptide drug discovery

23-Jun-2022 Iktos, a company specialized in Artificial Intelligence for new drug design, announced a research collaboration with Zealand Pharma A/S, a biotechnology company changing lives with innovative peptide-based medicines to co-develop generative and predictive AI technologies for peptide drug de ... more

CARMA FUND I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice

22-Jun-2022 A consortium of strong partners has launched the CARMA FUND I as a new vehicle for the translation of promising early-stage life-science projects: the initiators, Ascenion GmbH, a life-science focused technology transfer company of the LifeScience Foundation and the Goethe-University, Frank ... more

Spirea raises £2.4M to develop antibody drug conjugates in cancer

Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therapeutics for the treatment of solid tumours

21-Jun-2022 Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million ($3M) with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline o ... more

Pfizer will invest €90.5 million in Valneva

Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

20-Jun-2022 Valneva SE and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15. As previously announced on April 26, 2022, Pfizer plans to initiate the Phase 3 ... more

Gerresheimer partners with MedTech start-up Adamant Health to revolutionize treatment of Parkinson’s disease

Gerresheimer participates in seed-round of the Finnish MedTech company and university spin-off

15-Jun-2022 Gerresheimer AG and the Finnish start-up Adamant Health Oy partner up to develop a life-changing solution for millions of people worldwide suffering from Parkinson’s disease. The measuring technology and platform in development will address one of the biggest impediments in treating symptom ... more

Evotec enters a drug discovery collaboration with Janssen

Milestones up to approximately € 210 m per project

14-Jun-2022 Evotec SE announced that the Company has entered a drug discovery collaboration with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Evotec’s innovative TargetAlloMod platforms will be evaluated to discover first-in-class novel mode of action ther ... more

Early investors can forecast future of startup companies

Success comes in many forms

14-Jun-2022 For a movie, it could be box office numbers or critical acclaim. In academia, maybe it’s publishing research or helping students land dream jobs after graduation. New research from the University of Washington shows there are also multiple ways for startup companies to be successful. Early ... more

All news on pharma

Making it easier to differentiate mirror-image molecules

Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light

06-Jul-2022 Using a new method, scientists are better able to distinguish between mirror-image substances. This is important amongst others in drug development, because the two variants can cause completely different effects in the human body. Researchers from Paul Scherrer Institute PSI, EPF Lausanne ... more

The benefits of exercise in a pill?

Science is closer to that goal

06-Jul-2022 Researchers at Baylor College of Medicine, Stanford School of Medicine and collaborating institutions report in the journal Nature that they have identified a molecule in the blood that is produced during exercise and can effectively reduce food intake and obesity in mice. The findings impr ... more

On the way to cell-type materials

Physicists decode the dynamic interaction between molecular machines in metal-organic frameworks

05-Jul-2022 Molecular machines control a sizeable number of fundamental processes in nature. Embedded in a cellular environment, these processes play a central role in the intracellular and intercellular transportation of molecules, as well as in muscle contraction in humans and animals. In order for t ... more

Emerging Omicron subvariants are inhibited less efficiently by antibodies

Infections with the "old" omicron subvariants BA.1 and BA.2 provide little protection against the SARS-CoV-2 subvariant BA.5 causing a “summer wave” of cases in Germany

05-Jul-2022 The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current uptick of cases in Germany. However, it is at present largely unc ... more

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Investment will fund genomics startups for Illumina Accelerator Cambridge graduates

05-Jul-2022 Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in ... more

How bacteria adhere to cells: Basis for the development of a new class of antibiotics

04-Jul-2022 The adhesion of bacteria to host cells is always the first and one of the decisivesteps in the development of infectious diseases. The purpose of this adhesion by infectious pathogens is first to colonize the host organism (i.e., the human body), and then to trigger an infection, which in t ... more

More Brain Lesions in Senior Women than in Men of the Same Age

The Extent of Abnormalities in the Brain’s White Matter Grows Significantly After Menopause

04-Jul-2022 In women after menopause, the extent of certain brain lesions is larger than in men of the same age. DZNE researchers come to this conclusion based on the assessment of more than 3,400 adults as part of the Bonn Rhineland Study. A team led by neuroscientist Monique Breteler reports on the f ... more

Understanding how microbiota thrive in their human hosts

Inositol lipid production in gut bacteria unexpectedly widespread

01-Jul-2022 A research team lead by scientists from the Max Planck Institute for Biology, Tübingen, has now made substantial progress in understanding how gut bacteria succeed in their human hosts on a molecular level. They investigated how bacteria produce inositol lipids, substances vital for many ce ... more

Shining some light on the obscure proteome

Chemoproteomics draw the target landscape of HDAC drugs

01-Jul-2022 Mass-spectrometry based proteomics is the big-data science of proteins that allows the monitoring of the abundance of thousands of proteins in a sample at once. Therefore, it is a particularly well-suited readout for discovering which proteins are targeted by any small molecule. An internat ... more

Research on cell droplets – New hope for the treatment of neurodegenerative diseases

The Körber European Science Prize 2022 goes to Anthony Hyman

01-Jul-2022 The Körber European Science Prize 2022, endowed with one million euros, is to be awarded to the British cell biologist Anthony Hyman. In 2009, Hyman and his team – during studies on single-cell embryos of a threadworm – discovered a completely new state of biological matter: proteins can ac ... more

All news on healthcare
News by department
  • Products

    Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years

    In Long-Term Exploratory Analysis, TAK-003 Prevented 84% of Hospitalizations and 61% of Symptomatic Dengue Illness Overall

    13-Jun-2022 Takeda announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic dengue cases, with no important safety risks identified, in the overall population including both seropositive and seronegative individuals through four and a half ... more

    Start-up MIA Medical Information Analytics wins gold at the German Innovation Award

    Smart coding software, automated process solutions and professional services for the health sector

    01-Jun-2022 MIA Medical Information Analytics has been presented with a gold medal by the German Innovation Award. Using intelligent analysis tools, the Rhenus Group’s start-up creates an all-round data concept in the health care sector and provides long-term simplification for medical controlling at h ... more

    New therapeutic approach against rhinovirus infections

    Biotech-Start-up G.ST Antivirals starts first clinical trial

    16-May-2022 Less than three years after its foundation, the start-up G.ST Antivirals reaches a major milestone in the development of its lead asset and begins clinical phase I at the Vienna General Hospital. G.ST Antivirals is testing a nasal spray, which was developed specifically for use against cold ... more

  • Business

    Evotec completes acquisition of Rigenerand

    05-Jul-2022 Evotec SE announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed. Based out of Medolla, Italy, the cell technology company with leading edge in the field of cGMP manufacturing of cell therapies will operate as Evotec (Modena) Srl going for ... more

    Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

    Investment will fund genomics startups for Illumina Accelerator Cambridge graduates

    05-Jul-2022 Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in ... more

    WACKER to Invest Double-Digit Million-Euro Sum in Biotechnology Center

    The product portfolio is to expand through innovation, partnerships and acquisitions

    29-Jun-2022 The WACKER Group is concentrating its biotechnology research activities in Munich. The company is investing a double-digit million-euro sum in the construction of a Biotechnology Center, which is scheduled to be operational in 2024. This investment will strengthen WACKER’s biotechnology bus ... more

  • Price Development

    Are the high prices of cancer drugs justified?

    Does the cost correspond to the particular drug’s effectiveness in combating the disease?

    05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

  • Research

    Making it easier to differentiate mirror-image molecules

    Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light

    06-Jul-2022 Using a new method, scientists are better able to distinguish between mirror-image substances. This is important amongst others in drug development, because the two variants can cause completely different effects in the human body. Researchers from Paul Scherrer Institute PSI, EPF Lausanne ... more

    How to find marker genes in cell clusters

    New method facilitates identification of cell-type specific genes in single-cell data

    06-Jul-2022 The thousands of cells in a biological sample are all different and can be analyzed individually, cell by cell. Based on their gene activity, they can be sorted into clusters. But which genes are particularly characteristic of a given cluster, i.e. what are its “marker genes”? A new statist ... more

    The benefits of exercise in a pill?

    Science is closer to that goal

    06-Jul-2022 Researchers at Baylor College of Medicine, Stanford School of Medicine and collaborating institutions report in the journal Nature that they have identified a molecule in the blood that is produced during exercise and can effectively reduce food intake and obesity in mice. The findings impr ... more

  • People

    Harvesting metal catalysts from plants used for cleaning contaminated soils

    “Ecocatalyst” researcher Claude Grison wins European Inventor Award 2022

    23-Jun-2022 The European Patent Office honoured French scientist Claude Grison with the European Inventor Award 2022 in the "Research" category. The University professor and research director at the French National Centre for Scientific Research (CNRS) has developed a method of using plants to extract ... more

    Messenger RNA pioneer Katalin Karikó receives European Inventor Award 2022 for Lifetime achievement

    Her research work on modified mRNA paved the way to highly effective vaccines against COVID-19

    23-Jun-2022 The European Patent Office (EPO) honoured Hungarian-American researcher Katalin Karikó with the European Inventor Award 2022 in the category "Lifetime achievement", for her seminal work in developing modified messenger RNA (mRNA) for vaccines and medical therapies. For more than four decade ... more

    Cancer vaccine developers Madiha Derouazi and Elodie Belnoue laureates of the European Inventor Award 2022

    New medical platform to make therapeutic cancer vaccines that help the immune system recognise and destroy cancer cells in the body of a patient

    23-Jun-2022 The European Patent Office (EPO) distinguished Swiss biotechnologist Madiha Derouazi and French immunologist Elodie Belnoue with the European Inventor Award 2022 in the "SME" category. The pair have developed a vaccine assembly platform called KISIMA to produce vaccines for treating differe ... more

  • Finances

    Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

    Investment will fund genomics startups for Illumina Accelerator Cambridge graduates

    05-Jul-2022 Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in ... more

    Start-up NextImmune supported by Venture Kick

    Development of selective immunosuppressive drugs

    05-Jul-2022 NextImmune, a spin-off from the Biozentrum of the University of Basel, has received financial support of 150,000 Swiss francs from the Venture Kick funding initiative. The start-up develops a new generation of immunosuppressive drugs for autoimmune diseases and organ transplantation. The co ... more

    CARMA FUND I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice

    22-Jun-2022 A consortium of strong partners has launched the CARMA FUND I as a new vehicle for the translation of promising early-stage life-science projects: the initiators, Ascenion GmbH, a life-science focused technology transfer company of the LifeScience Foundation and the Goethe-University, Frank ... more

  • Cooperation

    Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design

    Collaboration leverages Iktos’ capabilities in machine learning and AI and Zealand expertise in peptide drug discovery

    23-Jun-2022 Iktos, a company specialized in Artificial Intelligence for new drug design, announced a research collaboration with Zealand Pharma A/S, a biotechnology company changing lives with innovative peptide-based medicines to co-develop generative and predictive AI technologies for peptide drug de ... more

    Pfizer will invest €90.5 million in Valneva

    Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15

    20-Jun-2022 Valneva SE and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License Agreement for Lyme disease vaccine candidate VLA15. As previously announced on April 26, 2022, Pfizer plans to initiate the Phase 3 ... more

    Merck Announces Collaboration with Agilent Technologies

    Collaboration will help enable real-time release and Bioprocessing 4.0

    15-Jun-2022 Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry i ... more

  • Technology

    The 7th BioProScale Symposium took place again as in-person event in Berlin

    New ways of thinking are required: Scientists from both academia and industry presented and discussed innovative approaches and developments in biotechnology and bioprocess engineering

    12-Apr-2022 On the subject of “Scaling Up and Down of Bioprocesses: Technological Innovation and Cell Physiology Insights”, the 7th Symposium was again held on-site in Berlin from March 28 to 31, 2022. In parallel, there was also the possibility to follow the presentations online. The symposium was org ... more

    World's first toxicology testing strategy without animal testing adopted by OECD

    Success for long-standing collaboration between BASF and Givaudan to develop and validate alternative methods

    30-Jun-2021 The world’s first toxicology testing strategy without animal testing has been approved by the OECD (Organisation for Economic Co-operation and Development). The testing strategy consists of three so-called alternative methods. They can be used to predict whether a substance causes allergic ... more

    6th BioProScale Symposium 2021 – held virtually for the first time

    Online event about the scale-up and scale-down for accelerated bioprocess development and optimization

    26-Apr-2021 From the 29 to 31 March 2021 the 6th BioProScale Symposium was held virtually for the first time. It was organized by the Chair of Bioprocess Engineering at Technische Universität Berlin, the Institute for Fermentation and Biotechnology in Berlin (IfGB) as part of the Versuchs- und Lehranst ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    M&A in chemicals and life sciences slowed down by global lockdowns

    Race for COVID-19 vaccine

    13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

  • Politics

    Chemical pollution threatens biodiversity

    Scientists say more environmental pollutants should be considered in species protection

    20-Jun-2022 Environmental chemical pollution threatens biodiversity. However, the complexity of this pollution remains insufficiently recognised by decision-makers - this is what international researchers led by Gabriel Sigmund from the University of Vienna and Ksenia Groh from the Swiss Federal Instit ... more

    CureVac and GSK Enter into Pandemic Preparedness Contract with German Government

    Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency

    12-Apr-2022 CureVac N.V. and GSK announced that they have entered into a contract with the German federal government to supply mRNA vaccines within a broader tender for pandemic preparedness in Germany. Following a setup period of a maximum of two years, the contract grants the German federal governmen ... more

    What the Biden-Harris administration means for chemistry

    The new administration has inherited a global pandemic and worsening climate change, among other science-related issues

    10-Feb-2021 The inauguration of Joe Biden and Kamala Harris marks a new era for science policy in the U.S. and beyond. The new administration has inherited a global pandemic and worsening climate change, among other science-related issues. A cover story in Chemical & Engineering News (C&EN), the weekly ... more

  • Manufacturing

    Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

    Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)

    27-Jun-2022 Merck announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new €59 million, 70,000 square foot facility, officially opened, b ... more

    Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S.

    Important contribution to the development of new mRNA therapies beyond COVID-19 vaccines

    03-Jun-2022 Evonik is building a new, highly flexible, global-scale production facility for pharmaceutical lipids in the United States. The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccin ... more

    Covalab invests more than €1 million in bioproduction operations for antibodies for Covid-19 diagnostics

    Company’s BioDiaThera project received almost €500,000 in subsidies as part of French ‘Capacity Building’ scheme

    25-May-2022 Covalab, a biotechnology company that specializes in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, announces that its BioDiaThera project has been awarded €491,152 ($520k) in funding as part of the French ‘Capacity Building’ scheme; ... more

  • Career

    High-Tech Business KNAUER Awarded for its Family Friendliness

    03-Nov-2021 The Berlin-based company makes sure its employees are well looked after, providing support for employees and their families, especially throughout the difficult times of the pandemic. KNAUER was officially recognized as the family friendliest company in Berlin that has more than 100 employe ... more

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE